Targacept Inc. (TRGT) News

News for Targacept Inc.  (TRGT) 
Sector News | Topic News
$ 6.07   -0.14 (-2.25%) Volume: 162.75 k 4:00 PM EST Feb 10, 2012
After Hours:  $ 6.11   0.04 (+0.66%) Volume: 670  4:27 PM EST Feb 10, 2012
View News From:  
Tue, Feb 07, 2012
8:55 AM Targacept to Report Fourth Quarter and 2011 Financial Results on February 21, 2012 - Business Wire
Mon, Feb 06, 2012
8:55 AM Targacept Announces Participation in Upcoming Conferences - Business Wire
Thu, Jan 05, 2012
8:55 AM Targacept Announces Decision by AstraZeneca to Advance AZD1446 in Alzheimer's Disease - Business Wire
Wed, Jan 04, 2012
8:55 AM Targacept to Present at the 30th Annual J.P. Morgan Healthcare Conference - Business Wire
7:00 AM Annual CNS Overview Issue Released by NeuroPerspective - Marketwire
Tue, Dec 20, 2011
2:02 AM AstraZeneca and Targacept Announce Top-line Results from Second Phase 3 Study of TC-5214 as an Adjunct Treatment in Patients with Major Depressive Disorder - Business Wire
Mon, Dec 05, 2011
8:00 AM Targacept Announces Initiation of Two Phase 2 Studies of TC-5619 - Business Wire
Mon, Nov 28, 2011
8:55 AM Targacept Announces Participation in Upcoming Conferences - Business Wire
Fri, Nov 11, 2011
9:00 AM Europe Situation Forecasts Change -- Report Highlights Wal-Mart Stores, Inc. and Targacept, Inc. - Marketwire
Thu, Oct 27, 2011
9:00 AM Analyst View, Impact of Global Events - Research Report on Targacept, Inc. and Acme Packet, Inc. - Marketwire
Fri, Oct 07, 2011
9:00 AM Expert's Economic Outlook, Global - Equity Research on Par Pharmaceutical Companies, Inc. and Targacept, Inc. - Marketwire
Mon, Oct 03, 2011
10:57 AM Alzheimer's Therapeutics Reviewed by NeuroPerspective - Marketwire
Tue, Jun 07, 2011
11:02 AM Pain Therapeutics Reviewed by NeuroPerspective - Marketwire
Wed, Apr 06, 2011
6:00 AM Schizophrenia Reviewed by NeuroInvestment - Marketwire
Wed, Mar 02, 2011
8:00 AM Parkinson's Therapeutics Reviewed by NeuroInvestment - Marketwire